Author:
Brown Chad,DiNunzio James,Eglesia Michael,Forster Seth,Lamm Matthew,Lowinger Michael,Marsac Patrick,McKelvey Craig,Meyer Robert,Schenck Luke,Terife Graciela,Troup Gregory,Smith-Goettler Brandye,Starbuck Cindy
Reference107 articles.
1. Albano A, Desai D et al (2012) Pharmaceutical composition. United States Patent & Trademark Office US20130172375 A1
2. Alie J, Menegotto J et al (2004) Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance. J Pharm Sciences 93:218–233.
3. Andrews GP, Jones DS et al (2008) The manufacture and characterisation of hot-melt extruded enteric tablets. Eur J Pharm Biopharm 69(1):264–273
4. Arkenau-Maric E, Bartholomaus J (2008) Process for the production of an abuse proofed dosage form, US 2008031197 A1, USPTO, pp 11.
5. Avella M, Martuscelli E et al (1991) Crystallization behaviour of poly (ethylene oxide) from poly (3-hydroxybutyrate)/poly (ethylene oxide) blends: phase structuring, morphology and thermal behaviour. Elsevier 32:1647–1653
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献